Melatonin in the Regulation of Sleep and Biological Rhythms

被引：0

作者：

I. V. Zhdanova ^{[1
]}

M. G. Poluektov ^{[2
]}

机构：

[1] Biochron LLC, Boston

[2] Sechenov First Moscow State Medical University (Sechenov University), Russian Ministry of Health, Moscow

来源：

Neuroscience and Behavioral Physiology | 2024年 / 54卷 / 7期

关键词：

chronic insomnia; internal clock; melatonin; melatonin therapy; sleep;

D O I：

10.1007/s11055-024-01693-9

中图分类号：

学科分类号：

摘要：

Melatonin, as a hormone of the circadian system, plays an important role in regulating physiological functions and facilitating adaptation to regular environmental changes. This review discusses the basics of circadian physiology directly related to the use of melatonin as hormone replacement therapy in older adults with decreased melatonin secretion and in the treatment of patients with chronic insomnia or circadian desynchronization. With stress on the importance of minimum effective doses, the use of both immediate- and sustained-release forms, the importance of regular dosing times, and the need to avoid bright light at times of elevated melatonin levels are discussed. Medical supervision is mandatory when using melatonin-containing drugs for the treatment of chronic insomnia. © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024.

引用

页码：939 / 944

页数：5

共 12 条

[1]

Zhdanova I.V., Sleep and its regulation in zebrafish, Rev. Neurosci, 22, 1, pp. 27-36, (2011)

[2]

Zhdanova I.V., Melatonin as a hypnotic: pro, Sleep Med. Rev, 9, 1, pp. 51-65, (2005)

[3]

Zhdanova I.V., Wurtman R.J., Lynch H.J., Et al., Sleep-inducing effects of low doses of melatonin ingested in the evening, Clin. Pharmacol. Ther, 57, 5, pp. 552-558, (1995)

[4]

Dollins A.B., Zhdanova I.V., Wurtman R.J., Et al., Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance, Proc. Natl. Acad. Sci. USA, 91, 5, pp. 1824-1828, (1994)

[5]

Zhdanova I.V., Wurtman R.J., Regan M.M., Et al., Melatonin treatment for age-related insomnia, J. Clin. Endocrinol. Metab, 86, 10, pp. 4727-4730, (2001)

[6]

Poluektov M.G., Tsenteradze S.L., Current concepts of insomnia syndrome and its treatments taking account of the International Classification of Sleep Disorders, Zh. Nevrol. Psikhiatr, 114, 11, pp. 92-97, (2014)

[7]

Morin C.M., Belanger L., LeBlanc M., Et al., The natural history of insomnia: a population-based 3-year longitudinal study, Arch. Intern. Med, 169, 5, pp. 447-453, (2009)

[8]

Lemoine P., Zisapel N., Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia, Expert Opin. Pharmacother, 13, 6, pp. 895-905, (2012)

[9]

Zisapel N., New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation, Br. J. Pharmacol, 175, 16, pp. 3190-3199, (2018)

[10]

Morin C.M., Koetter U., Bastien C., Et al., Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial, Sleep, 28, 11, pp. 1465-1471, (2005)

← 1 2 →